These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18419640)

  • 1. CYP2C9 polymorphism in non-steroidal anti-inflammatory drugs-induced gastropathy.
    Ma J; Yang XY; Qiao L; Liang LQ; Chen MH
    J Dig Dis; 2008 May; 9(2):79-83. PubMed ID: 18419640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.
    Pilotto A; Seripa D; Franceschi M; Scarcelli C; Colaizzo D; Grandone E; Niro V; Andriulli A; Leandro G; Di Mario F; Dallapiccola B
    Gastroenterology; 2007 Aug; 133(2):465-71. PubMed ID: 17681167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding.
    Blanco G; Martínez C; Ladero JM; Garcia-Martin E; Taxonera C; Gamito FG; Diaz-Rubio M; Agundez JA
    Pharmacogenet Genomics; 2008 Jan; 18(1):37-43. PubMed ID: 18216720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic variants of cytochrome P450 2C9 modify the interaction between nonsteroidal anti-inflammatory drugs and coumarin anticoagulants.
    Visser LE; van Schaik RH; van Vliet M; Trienekens PH; De Smet PA; Vulto AG; Hofman A; van Duijn CM; Stricker BH
    Clin Pharmacol Ther; 2005 Jun; 77(6):479-85. PubMed ID: 15961979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2C9*3 Loss-of-Function Allele Is Associated With Acute Upper Gastrointestinal Bleeding Related to the Use of NSAIDs Other Than Aspirin.
    Carbonell N; Verstuyft C; Massard J; Letierce A; Cellier C; Deforges L; Saliba F; Delchier JC; Becquemont L
    Clin Pharmacol Ther; 2010 Jun; 87(6):693-8. PubMed ID: 20445534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 CYP2C9 polymorphism and NSAID-related acute gastrointestinal bleeding.
    Agúndez JA; Martínez C; García-Martín E; Ladero JM
    Gastroenterology; 2007 Dec; 133(6):2071-2; author reply 2072-3. PubMed ID: 18054585
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of cytochrome P450 2C9 genotype for the bleeding complications in patients treated with acenocoumarol].
    Márk L; Márki-Zay J; Fodor L; Kondacs A; Paragh G; Katona A
    Orv Hetil; 2005 Apr; 146(16):739-43. PubMed ID: 15889670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in genes encoding acetylsalicylic acid metabolizing enzymes are unrelated to upper gastrointestinal health in cardiovascular patients on acetylsalicylic acid.
    van Oijen MG; Huybers S; Peters WH; Drenth JP; Laheij RJ; Verheugt FW; Jansen JB
    Br J Clin Pharmacol; 2005 Dec; 60(6):623-8. PubMed ID: 16305586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P4502C9 genotype in Southeast Anatolia and possible relation with some serum tumour markers and cytokines.
    Yilmaz N; Erbağci AB; Aynacioğlu AS
    Acta Biochim Pol; 2001; 48(3):775-82. PubMed ID: 11833786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No modification of the beneficial effect of NSAIDs on colorectal cancer by CYP2C9 genotype.
    Siemes C; Eijgelsheim M; Dieleman JP; van Schaik RH; Uitterlinden AG; van Duijn CM; Hofman A; Coebergh JW; Stricker BH; Visser LE
    Neth J Med; 2009 Apr; 67(4):134-41. PubMed ID: 19581657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors].
    Karateev AE; Nasonova VA
    Ter Arkh; 2008; 80(5):62-6. PubMed ID: 18590118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population.
    Yasar U; Eliasson E; Dahl ML; Johansson I; Ingelman-Sundberg M; Sjöqvist F
    Biochem Biophys Res Commun; 1999 Jan; 254(3):628-31. PubMed ID: 9920790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The assessment of the effect of glucocorticosteroid and nonsteroidal anti-inflammatory preparations on the development of an erosive-ulcerative lesion of the gastrointestinal tract in patients with rheumatic diseases].
    Karateev AE; Nasonova VA; Murav'ev IuV
    Ter Arkh; 1999; 71(2):26-30. PubMed ID: 10222549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interethnic differences of CYP2C9 alleles in healthy Hungarian and Roma population samples: relationship to worldwide allelic frequencies.
    Sipeky C; Lakner L; Szabo M; Takacs I; Tamasi V; Polgar N; Falus A; Melegh B
    Blood Cells Mol Dis; 2009; 43(3):239-42. PubMed ID: 19541511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2C9 gene and susceptibility to major depressive disorder.
    LLerena A; Berecz R; Dorado P; González AP; Peñas-LLedó EM; De La Rubia A
    Pharmacogenomics J; 2003; 3(5):300-2. PubMed ID: 14583800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A NSAID-associated alimentary tract disease in patients with rheumatism in Russia].
    Karataev AE; Konovalova NN; Litovshenko AA; Lomareva NI; Nemtsov BF; Raskina TA; Peshekhonova LK; Nasonov EL
    Klin Med (Mosk); 2005; 83(5):33-8. PubMed ID: 15984580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a synonymous polymorphism within the cytochrome P4502C9 gene that interferes with identification of the CYP2C9*2 allele.
    Womack EP; Reynolds KK; Valdes R; Linder MW
    Ther Drug Monit; 2007 Oct; 29(5):607-11. PubMed ID: 17898651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 2C9 polymorphism and acenocoumarol therapy.
    Mark L; Marki-Zay J; Fodor L; Hajdara I; Paragh G; Katona A
    Kardiol Pol; 2006 Apr; 64(4):397-402; discussion 403-4. PubMed ID: 16699986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lornoxicam pharmacokinetics in relation to cytochrome P450 2C9 genotype.
    Zhang Y; Zhong D; Si D; Guo Y; Chen X; Zhou H
    Br J Clin Pharmacol; 2005 Jan; 59(1):14-7. PubMed ID: 15606435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CYP2C9 gene polymorphisms on anticoagulant therapy after heart valve replacement.
    Yildirim H; Tamer L; Sucu N; Atik U
    Med Princ Pract; 2008; 17(6):464-7. PubMed ID: 18836275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.